Corticotropin-releasing Factor

نویسنده

  • Jurgen Lenz
چکیده

Introduction Immunoreactivity similar to that of corticotropin-releasing factor (CRF) is found in regions of the central nervous system that modulate autonomic responses, including gastrointestinal functions. We examined the central nervous system effects of ovine CRF on gastric acid secretion in conscious dogs. Male beagle dogs (11-13 kg) were fitted with chronic intracerebroventricular cannulae and gastric fistulae. Gastric acid secretion in response to intravenously administered gastric secretory stimuli was measured by in vitro titration of gastric juice to pH 7.0 and in response to an intragastric meal by in vivo intragastric titration at pH 5.0. Plasma gastrin was determined by radioimmunoassay. CRF microinjected into the third cerebral ventricle decreased pentagastrin-stimulated gastric acid secretion for 3 h (P < 0.01) dose-dependently (0.2-6.0 nmol kg-'). CRF did not inhibit histamine-stimulated gastric secretion but significantly (P < 0.01) decreased the secretory response after 2-deoxy-D-glucose for 3 h. The gastric inhibitory action of intracerebroventricularly administered CRF on pentagastrinstimulated gastric acid secretion was completely abolished by ganglionic blockade with chlorisondamine. The opioid antagonist, naloxone, and the vasopressin antagonist, 1l-deaminopenicillamine,240--methyl)tyrosine,8-argininel-vasopressin, significantly suppressed the inhibitory effect of CRF on gastric acid secretion stimulated by pentagastrin. In contrast, truncal vagotomy did not prevent the inhibition of gastric acid secretion induced by CRF. CRF (0.2-2.0 nmolk kg-') administered intracerebroventricularly decreased gastric acid secretion stimulated by 200-ml liquid meals containing 8% peptone. CRF did not affect plasma gastrin concentrations. These results indicate that CRF microinjected into the third cerebral ventricle inhibits gastric acid secretion in conscious dogs. CRF-induced inhibition of gastric acid secretion appears to be mediated by the sympathetic nervous system and, in part, by opiate and vasopressindependent mechanisms. A portion of this report was presented at the 85th Annual Meeting of the American Gastroenterological Association, 19-25 May 1984, New Orleans, LA, and has appeared in abstract form (1984. Gastroenterology. 86:1158). Address correspondence to Dr. Brown. Received for publication 1I June 1984 and in revised form 13 November 1984. Corticotropin-releasing factor (CRF)' is a 41-residue peptide isolated from ovine (1) and rat hypothalami (2). The primary structure of human CRF that is identical to the amino acid sequence of rat CRF was derived from the nucleotide sequence of the cloned DNA (3). CRF stimulates the release of ACTH and f3-endorphin in vivo and in vitro (1). Furthermore, the distribution of CRFlike immunoreactivity within the central nervous system suggests that CRF-containing pathways in the brain are involved in the mediation of autonomic responses (4). CRF administered intracerebroventricularly (i.c.v.) to rats results in activation of the sympathetic nervous system resulting in elevated plasma catecholamine and glucose concentrations (5) as well as in increased mean arterial pressure and heart rate (6). CRF also increases oxygen consumption (7) and motor activity in the rat (8) but decreases sexual behavior (9), food intake (10), and gastric acid secretion (1 1). In the dog, CRF administered i.c.v. activates the sympathetic nervous system and increases plasma vasopressin concentrations (12). The aforementioned central nervous system actions of CRF and the recent demonstration that a CRF antagonist diminished the ACTH release normally observed after either stress (13) imply that CRF may be involved in generating integrated endocrine and autonomic responses to stress (14). The purpose of this study was to examine the central nervous system effects of CRF on gastric acid secretion and to study the mechanism(s) of its action in conscious dogs. In particular, we attempted to assess the role of the autonomic nervous system in mediating the biologic actions of CRF on gastric acid secretion.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology?

New corticotropin releasing factor (CRF) antagonists in irritable bowel disease (IBS) warrant testing, and CRF1 receptors may be a promising target for the treatment of IBS.

متن کامل

Neuroprotection by corticotropin releasing factor during hypoxia in rat brain.

BACKGROUND AND PURPOSE Corticotropin releasing factor is an endogenous neuropeptide released by the hypothalamus that activates the pituitary-adrenocortical system in response to stressful stimuli. It has been demonstrated that corticotropin releasing factor increases the excitability of hippocampal neurons in both in vitro and in vivo studies, which may contribute to neurological injury during...

متن کامل

Corticotropin-Releasing Factor Mediates Pain-Induced Anxiety through the ERK1/2 Signaling Cascade in Locus Coeruleus Neurons

BACKGROUND The corticotropin-releasing factor is a stress-related neuropeptide that modulates locus coeruleus activity. As locus coeruleus has been involved in pain and stress-related patologies, we tested whether the pain-induced anxiety is a result of the corticotropin-releasing factor released in the locus coeruleus. METHODS Complete Freund's adjuvant-induced monoarthritis was used as infl...

متن کامل

Chronic amphetamine treatment enhances corticotropin-releasing factor-induced serotonin release in the amygdala.

Amphetamine use is associated with dysphoric states, including heightened anxiety, that emerge within 24h of withdrawal from the drug. Corticotropin-releasing factor increases serotonin release in the central nucleus of the amygdala, and this neurochemical circuitry may play a role in mediating fear and anxiety states. We have previously shown that chronic amphetamine treatment increases cortic...

متن کامل

Brain corticotropin releasing factor in the spontaneously hypertensive rat.

Corticotropin releasing factor and vasopressin were measured in major brain regions including the neurohypophysis in spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto rats (WKY) during development of hypertension. The highest concentration of corticotropin releasing factor was found in the hypothalamus in both strains. Corticotropin releasing factor was decreased in most major...

متن کامل

Adrenocorticotropin responses to corticotropin releasing factor and vasopressin in spontaneously hypertensive rats.

The effects of exogenous corticotropin releasing factor and arginine vasopressin were evaluated in 6- and 11-week-old spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto rats (WKY). Basal adrenocorticotropic hormone (ACTH) and vasopressin levels did not differ between SHR and WKY, but basal corticosterone level was higher in 6-week-old SHR (p less than 0.01). To block endogenous...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2013